Pasireotide Extended-Release Injection and Rifampin Capsules
Determining the interaction of Pasireotide Extended-Release Injection and Rifampin Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: rifampin
Brand name: Rifadin, Rifadin IV, Rimactane
Synonyms: Rifampin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Rifampin Injection
- Pasireotide Extended-Release Injection-Rifampin Intravenous
- Pasireotide Extended-Release Injection-Rifampin Oral, Intravenous
- Pasireotide Extended-Release Injection-Rifampin, Isoniazid, and Pyrazinamide
- Pasireotide Extended-Release Injection-Rifamycin
- Pasireotide Extended-Release Injection-Rifamycin Sodium
- Rifampin Capsules-Pasireotide Injection
- Rifampin Capsules-Pasireotide Subcutaneous
- Rifampin Capsules-Patanase
- Rifampin Capsules-Patiromer
- Rifampin Capsules-Patiromer Sorbitex Calcium
- Rifampin Capsules-Pavacot